StockMarketWire.com - Finnish-based biopharmaceutical group Faron Pharmaceuticals launched a share issue to raise up to around £15.0m to accelerate its commercialisation strategy.

New shares would be issued at 805p each, which the company said represented the closing mid-market price of 805p on Thursday.

At 2:25pm: [LON:FARN] Faron Pharmaceuticals share price was +35p at 840p



Story provided by StockMarketWire.com